Advances in Molecular Biomarkers in Cardiology
- PMID: 36291738
- PMCID: PMC9599388
- DOI: 10.3390/biom12101530
Advances in Molecular Biomarkers in Cardiology
Abstract
Cardiovascular diseases (CVD) represent the leading cause of death in the world despite innovations in therapies and advances in the general management of patients [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Roth G.A., Mensah G.A., Johnson C.O., Addolorato G., Ammirati E., Baddour L.M., Barengo N.C., Beaton A.Z., Benjamin E.J., Benziger C.P., et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J. Am. Coll. Cardiol. 2020;76:2982–3021. doi: 10.1016/j.jacc.2020.11.010. - DOI - PMC - PubMed
-
- FDA-NIH Biomarker Working Group . BEST (Biomarkers, EndpointS, and Other Tools) Resource. Food and Drug Administration (US); Silver Spring, MD, USA: National Institutes of Health (US); Bethesda, MD, USA: [(accessed on 6 September 2022)]. Available online: www.ncbi.nlm.nih.gov/books/NBK326791/
-
- Aguilar-Iglesias L., Merino-Merino A., Sanchez-Corral E., Garcia-Sanchez M.J., Santos-Sanchez I., Saez-Maleta R., Perez-Rivera J.A. Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure. Biomolecules. 2022;12:245. doi: 10.3390/biom12020245. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
